Onconephrology is a new subspecialty of nephrology that recognizes the important
intersections of kidney disease with cancer. This intersection takes many forms and includes …

Monoclonal Gammopathy of Renal Significance Monoclonal gammopathy of renal
significance is a B-cell or plasma-cell clonal disorder that does not meet the criteria for …

In November 2017, the Kidney Disease: Improving Global Outcomes (KDIGO) initiative
brought a diverse panel of experts in glomerular diseases together to discuss the 2012 …

Glomerulonephritis is a heterogeneous group of disorders that present with a combination of
haematuria, proteinuria, hypertension, and reduction in kidney function to a variable degree …

Background Treatment of proliferative GN with monoclonal Ig deposits (PGNMID) is not
established. A monoclonal anti-CD38 antibody (daratumumab) is effective in treating …

Proliferative glomerulonephritis (GN) with monoclonal immunoglobulin deposits (PGNMIDs)
is a recently described entity among the spectrum of monoclonal gammopathy of renal …

Recent years have witnessed a rapid growth in our understanding of the pathogenic
property of monoclonal proteins. It is evident that some of these small monoclonal proteins …

Acute kidney injury (AKI) is common in patients with cancer, especially in those with
haematological malignancies. Kidney injury might be a direct consequence of the …

Monoclonal gammopathy of clinical significance (MGCS) represents a new clinical entity
referring to a myriad of pathological conditions associated with the monoclonal gammopathy …

IgG (mainly IgG3) is the most commonly involved isotype in proliferative glomerulonephritis
with monoclonal immunoglobulin deposits (PGNMID). Here we describe the first series of …